Vitasora Health Limited VHLUF
—
0.00
0.00
NaN
as of 24 Sep
- Market cap
- —
- P/E
- —
Follow VHLUF
Growth Flags
show if company had growth for consecutive years
| Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | Jun '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(0.02) | 0.00 | (0.02) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
(0.02) | 0.00 | (0.02) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.52 | 0.30 | 0.09 | 1.06 | 5.53 | 1.78 | 0.18 | 0.18 | — | — |
Current Ratio |
1.46 | 1.18 | 1.34 | 3.44 | 6.10 | 2.22 | 0.39 | 0.39 | — | — |
Net Debt/EBITDA |
0.04 | 0.10 | 0.03 | 0.19 | 0.72 | 0.39 | (0.06) | 0.07 | 0.00 | 0.00 |
Debt/Assets |
0.00% | 0.93% | 0.00% | 0.00% | 0.00% | 15.53% | 79.57% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.29 | (0.52) | 0.00 | — | — |
Asset Turnover |
0.30 | 0.22 | 0.17 | 0.11 | 0.22 | 0.77 | 1.02 | 1.88 | 0.00 | 0.00 |
Operating CF/Net income |
0.91 | 0.93 | 0.78 | 1.28 | 0.66 | 0.65 | 0.76 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
0.00 | 0.00 | (0.28) | (0.03) | 0.00 | (1.23) | (0.70) | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (116.56%) | (409.05%) | (283.90%) | (122.62%) | (225.03%) | (1,748.82%) | 15.30% | 0.00% | 0.00% | 0.00% | |
| (81.91%) | (150.78%) | (149.74%) | (97.52%) | (166.54%) | (254.84%) | (836.12%) | (686.16%) | 0.00% | 0.00% | |
ROIC |
(44.24%) | (228.58%) | (528.83%) | (231.23%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(599.65%) | (1,131.51%) | (612.17%) | (220.23%) | (144.49%) | (276.84%) | 541.89% | 222.35% | 0.00% | 0.00% |
Average Days of Receivables |
149.92 | 88.96 | 26.04 | 23.57 | 34.53 | 1.35 | 57.20 | 61.87 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
6.51% | 13.20% | 57.06% | 187.85% | 96.50% | 92.23% | 410.87% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
114.99% | 337.60% | 291.20% | 310.77% | 441.72% | 252.89% | 357.13% | 552.02% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.71 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
31.63% | 51.73% | 50.71% | 54.18% | 0.00% | 145.89% | 168.59% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.01) | (0.01) | 0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.01) | (0.01) | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
(5.94) | (4.36) | (3.04) | (6.15) | (5.52) | (3.16) | (4.59) | — | — | — |
Working Capital |
1.08 | 0.40 | 0.52 | 2.12 | 5.59 | 1.64 | (1.13) | (1.13) | — | — |
Capital Expenditures |
— | — | (0.01) | 0.00 | (0.04) | (0.01) | 0.00 | — | — | — |
Net Current Asset Value |
1.04 | 0.32 | 0.44 | 2.12 | 5.54 | 1.55 | (1.13) | (1.13) | — | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.03 | 0.00 | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(272.72%) | (686.45%) | (872.31%) | (850.30%) | (768.09%) | (328.99%) | (821.72%) | (364.66%) | (300.32%) | (586.75%) |
| Other line items | ||||||||||
Depreciation/Fixed assets |
4.94 | 2.96 | 0.44 | 0.99 | 0.00 | 0.06 | 0.49 | 0.00 | — | — |
Cash ROIC |
(60.95%) | (192.72%) | (479.55%) | (202.61%) | (48.26%) | (72.08%) | 1,428.37% | 0.76% | — | — |
Accounts Receivable Turnover |
4.17 | 6.89 | 13.05 | 8.19 | 20.06 | 24.48 | 6.38 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.05 | 0.24 | 1.09 | 0.00 | — | — | — | — |
Inventory Turnover |
0.00 | 0.00 | 0.03 | 0.16 | 3.10 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 10,262.12 | 1,111.69 | 373.97 | 0.00 | 0.00 | — | — | — |
Days of Inventory on Hand |
0.00 | 0.00 | 6,847.47 | 3,732.28 | 155.15 | 0.00 | — | — | — | — |
Average Receivables |
0.58 | 0.10 | 0.03 | 0.07 | 0.05 | 0.06 | 0.12 | — | — | — |
Average Payables |
1.67 | 1.26 | 0.91 | 0.77 | 0.86 | 1.01 | — | — | — | — |
Average Inventory |
1.84 | 1.32 | 1.38 | 1.16 | 0.30 | — | — | — | — | — |
Average Assets |
7.99 | 3.10 | 2.60 | 4.93 | 4.95 | 1.91 | 0.72 | 0.36 | 0.00 | — |
Average Common Equity |
5.61 | 1.14 | 1.37 | 3.92 | 3.67 | 0.28 | (39.61) | — | — | — |
Columns are period end dates